Cargando…
Survival in elderly patients with breast cancer with and without autoimmune disease
BACKGROUND: Patients with certain autoimmune conditions are at a reduced risk of developing breast cancer compared to the general population. Despite this, little is known about outcomes in patients with breast cancer who have a concurrent autoimmune diagnosis. METHODS: This study compared differenc...
Autores principales: | Dedousis, Demitrios, Zhang, Annie L., Vassiliou, Anastasia N., Cao, Shufen, Yammani, Deepthi, Kyasaram, Ravi K., Shanahan, John P., Keinath, Melissa C., Hsu, Melinda L., Fu, Pingfu, Dowlati, Afshin, Montero, Alberto J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315719/ https://www.ncbi.nlm.nih.gov/pubmed/37102221 http://dx.doi.org/10.1002/cam4.5989 |
Ejemplares similares
-
Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease
por: Dedousis, Demitrios, et al.
Publicado: (2022) -
A randomized controlled trial of structured palliative care versus standard supportive care for patients enrolled in phase 1 clinical trials
por: Treasure, Michelle, et al.
Publicado: (2021) -
A detailed smoking history and determination of MYC status predict response to checkpoint inhibitors in advanced non-small cell lung cancer
por: Chiu, Michelle, et al.
Publicado: (2020) -
RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR
por: Sakre, Nneha, et al.
Publicado: (2016) -
Adding Base-Excision Repair Inhibitor TRC102 to Standard Pemetrexed–Platinum–Radiation in Patients with Advanced Nonsquamous Non–Small Cell Lung Cancer: Results of a Phase I Trial
por: Biswas, Tithi, et al.
Publicado: (2022)